Literature DB >> 18675828

UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.

Hugo Girard1, Lesley M Butler, Lyne Villeneuve, Robert C Millikan, Rashmi Sinha, Robert S Sandler, Chantal Guillemette.   

Abstract

Glucuronidation by the UDP-glucuronosyltransferase enzymes (UGTs) is one of the primary detoxification pathways of dietary heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs). In a population-based case-control study of 537 cases and 866 controls, we investigated whether colon cancer was associated with genetic variations in UGT1A1 and UGT1A9 genes and we determined if those variations modify the association between colon cancer and dietary HCA and PAH exposure. We measured functional UGT1A1 polymorphisms at positions -53 (28; A(TA)6TAA to A(TA)7TAA), -3156 (G>A), -3279 (T>G) and the UGT1A9-275(T>A) polymorphism, and found no association with colon cancer overall. However, when stratified by race, the UGT1A1-3279 GG/TG intermediate/low activity genotypes were associated with an increased risk of colon cancer (odds ratio (OR)=1.5, 95% confidence interval (CI)=1.1-2.0) in Caucasians. This finding is also supported by haplotype analyses where the UGT1A1-3279G-allele-bearing haplotype is overrepresented in case group. Overall, UGT1A1-53 and -3156 genotypes modified the association between dietary benzo(a)pyrene (BaP) and colon cancer (P for interaction=0.02 and 0.03, respectively). The strongest association was observed for those with <7.7 ng/day BaP exposure and the low activity genotypes, for both UGT1A1 28/28 (OR=1.8, 95% CI=1.1-2.9) and -3156AA (OR=1.7, 95% CI=1.0-3.0), compared to >or=7.7 ng/day and combined high/intermediate genotypes. These data support a hypothesis that UGTs modify the association between meat-derived PAH exposure and colon cancer by their role in the elimination of dietary carcinogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675828      PMCID: PMC2570038          DOI: 10.1016/j.mrfmmm.2008.07.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  54 in total

1.  Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies.

Authors:  R Sinha; N Rothman
Journal:  Mutat Res       Date:  1997-05-12       Impact factor: 2.433

2.  Genetic-environmental interactions and low-level exposure to carcinogens.

Authors:  P Vineis; T Martone
Journal:  Epidemiology       Date:  1995-07       Impact factor: 4.822

3.  Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry.

Authors:  T E Aldrich; D Vann; P G Moorman; B Newman
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

4.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

Authors:  L Excoffier; M Slatkin
Journal:  Mol Biol Evol       Date:  1995-09       Impact factor: 16.240

5.  Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens.

Authors:  P Vineis; H Bartsch; N Caporaso; A M Harrington; F F Kadlubar; M T Landi; C Malaveille; P G Shields; P Skipper; G Talaska
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

6.  Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes.

Authors:  K R Kaderlik; G J Mulder; J G Shaddock; D A Casciano; C H Teitel; F F Kadlubar
Journal:  Carcinogenesis       Date:  1994-08       Impact factor: 4.944

7.  Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).

Authors:  H C Chou; N P Lang; F F Kadlubar
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

8.  Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans.

Authors:  R Sinha; N Rothman; E D Brown; S D Mark; R N Hoover; N E Caporaso; O A Levander; M G Knize; N P Lang; F F Kadlubar
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.

Authors:  M Ciotti; F Chen; F F Rubaltelli; I S Owens
Journal:  Biochim Biophys Acta       Date:  1998-07-01

10.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

View more
  28 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

2.  Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.

Authors:  Dongfang Tang; Yu C Zhao; Hongliang Liu; Sheng Luo; Jeffrey M Clarke; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Wen Gao; Qingyi Wei
Journal:  Int J Cancer       Date:  2020-03-09       Impact factor: 7.396

Review 3.  Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine.

Authors:  Yaqiong Jin; Geng Chen; Wenming Xiao; Huixiao Hong; Joshua Xu; Yongli Guo; Wenzhong Xiao; Tieliu Shi; Leming Shi; Weida Tong; Baitang Ning
Journal:  Sci China Life Sci       Date:  2019-05-20       Impact factor: 6.038

4.  Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk.

Authors:  Rick J Jansen; Dennis P Robinson; Rachael Z Stolzenberg-Solomon; William R Bamlet; XiangLin Tan; Julie M Cunningham; Ying Li; David N Rider; Ann L Oberg; Kari G Rabe; Kristin E Anderson; Rashmi Sinha; Gloria M Petersen
Journal:  Pancreas       Date:  2013-10       Impact factor: 3.327

Review 5.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

6.  Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.

Authors:  Ryan T Bushey; Gang Chen; Andrea S Blevins-Primeau; Jacek Krzeminski; Shantu Amin; Philip Lazarus
Journal:  Pharmacogenet Genomics       Date:  2011-02       Impact factor: 2.089

7.  Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Authors:  Dong Liang; Larissa Meyer; David W Chang; Jie Lin; Xia Pu; Yuanqing Ye; Jian Gu; Xifeng Wu; Karen Lu
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

8.  Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer.

Authors:  Anne M J Gilsing; Sonja I Berndt; Elizabeth H Ruder; Barry I Graubard; Leah M Ferrucci; Laura Burdett; Joel L Weissfeld; Amanda J Cross; Rashmi Sinha
Journal:  Carcinogenesis       Date:  2012-05-02       Impact factor: 4.944

9.  Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism.

Authors:  Misty R Saracino; Jeannette Bigler; Yvonne Schwarz; Jyh-Lurn Chang; Shiuying Li; Lin Li; Emily White; John D Potter; Johanna W Lampe
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

10.  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Sheri Trudeau; Andrew Rundle; Satoru Takahashi; Tomoyuki Shirai; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2013-03-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.